InhaleRx Limited (IRX.AX)
InhaleRx Limited operates in the Medical - Devices industry of the Healthcare sector, headquartered in Sydney, NSW, AU. The stock last traded at $0.03, up 0.00% on the session, giving a market capitalisation of $6.9M. Its beta of -0.29 implies it has historically moved less than the broad market.
Established in 2016 and headquartered in Sydney, Australia, InhaleRx Limited is an Australian company primarily engaged in advancing and bringing to market medical drug delivery systems. The firm also dedicates efforts to developing specialized inhaled drug formulations. A notable product within its portfolio is the Medihale inhaler, a distinctive sealed-pod device engineered for compatibility with its inhaled medications. This entity formerly traded as Lifespot Health Ltd, officially adopting the name InhaleRx Limited in October 2021.
InhaleRx Limited is most often compared with the following Healthcare names: